Say panagtambal ed kanser ed bala et akadepende ed pigaran bengatla, singa say stage na kanser, klase na kanser, tan say kipapasen na laman na pasyente.
Arum ed saray kaslakan a paraan na panagtambal et:
1. Surgery: Mabetbet a saya so mas labay a paraan na panambal ed kanser ed bala diad primeron yugto.
Ekalen na doktor so tumor tan daiset a laman ed kaliberliber na satan.
2. Radiation therapy: Uusaren so high-energy radiation pian pateyen iray selula na kanser tan pakapuyen iray tumor.
Nayari itan ya usaren a bukor odino kaiba na arum nin panagtambal.
3. Chemotherapy: Sayan panagtambal et uusaren iray druga pian pateyen iray selula na kanser.
Nayari itan ya ipa-intravenously odino ipa-oral, tan mabetbet ya uusaren itan a kaiba so arum nin panagtambal.
4. Targeted therapy: Sayan panagtambal et i-target toy espisipikon genes odino protina ya ontutulong ed ibaleg tan panbilay na saray selula na kanser.
Mabetbet itan ya uusaren ed advanced odino metastatic lung cancer.
5. Immunotherapy: Ontulong iyan panagtambal ed immune system pian nabidbir tan atakien iray selula na kanser.
Mabetbet itan ya uusaren ed advanced odino metastatic lung cancer.
6. Photodynamic therapy: Sayan panagtambal et uusaren so sakey a tambal a papapawayen na liwawa pian pateyen iray selula na kanser.
Mabetbet itan ya uusaren ed kanser ed bala diad primeron yugto.
7. Proton therapy: Sakey iyan klase na radiation therapy ya uusaren iray proton imbes ya x-ray pian ipaarap so radiation ed tumor.
Mabetbet itan ya uusaren ed kanser ed bala diad primeron yugto.
8. Klinikal iran panagsubok: Saray pasyente so nayarin kualipikado a mibiang ed saray klinikal a panagsubok a manubok ed saray balon panagtambal odino kombinasyon na saray panagtambal.
Importante ya pantongtongan yo iray sankaabigan a paraan na panagtambal a kaiba so healthcare team, lapud say sankamaepektiboan a paraan na panagtambal et akadepende ed situasyon na kada too.
Chen JH, Wu J, Xu Q: The emerging treatment landscape of targeted therapy in non-small-cell lung cancer. Signal Transduct Target Ther. , 4 (): 61.
Furuse K: [Photodynamic therapy of centrally located early-stage lung cancer]. Gan To Kagaku Ryoho. 1996, 23 (1): 27-30.
Gálffy G: [From rare mutations to classical ones, inhibition of signaling pathways in non-small cell lung cancer]. Magy Onkol. 2020, 64 (3): 196-204.
Magalhães M, Alvarez-Lorenzo C, Concheiro A, Figueiras A, Santos AC, Veiga F: RNAi-based therapeutics for lung cancer: biomarkers, microRNAs, and nanocarriers. Expert Opin Drug Deliv. 2018, 15 (10): 965-982.
Kataoka M, Fujiwara T, Tanaka N: [Gene therapy for lung cancer]. Nihon Geka Gakkai Zasshi. 2002, 103 (2): 244-9.
Jin C, Yang B: A Case of Delayed Diagnostic Pulmonary Tuberculosis during Targeted Therapy in an EGFR Mutant Non-Small Cell Lung Cancer Patient. Case Rep Oncol. , 14 (1): 659-663.
Wang Y, Liu Q, Chen H, You J, Peng B, Cao F, Zhang X, Chen Q, Uzan G, Xu L, Zhang D: Celastrol improves the therapeutic efficacy of EGFR-TKIs for non-small-cell lung cancer by overcoming EGFR T790M drug resistance. Anticancer Drugs. 2018, 29 (8): 748-755.
['Disclaimer: medikal']
['Sayan website et parad edukasyon tan impormasyon labat tan agmangiter na medikal a simbawa odino propesyonal a serbisyo.']
['Say impormasyon ya intarya so agnepeg ya usaren pian nadiagnose odino natambal so problema ed bunigas odino sakit, tan saramay manaanap na personal a medikal a simbawa so nepeg a mankonsulta ed sakey a lisensiadon doktor.']
['Tandaan ya say neural network ya uusaren pian naebatan iray tepet et aliwan susto no bilang so usaren, singa bilang na totoon walay sakit da.']
['Lawas onkerew na simbawa ed doktor odino arum nin kualipikadon health provider nipaakar ed sakit mo. Agmon balot ibabaliwala so simbawa na doktor odino itutunda itan lapud walay abasam ed sayan website. No iisipen mon walay emergency mo, tawagan so 911 odino onla kan tampol ed sankaasinggeran ya emergency room.']
['Disclaimer: copyright']
['Say Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (say DMCA) et mangiiter na legal a tulong ed saray akankayarian na copyright no manisia ran say materyal ya walad Internet et onkokontra ed kanepegan da. ']
['No manisia ka ya walay karga odino materyal ya in-post ed website odino diad saray serbisyo mi ya onkokontra ed copyright mo, sarag mo (odino say representative mo) ya ipawit ed sikami so sakey a sulat ya mangibagan ekalen mi so karga odino materyal, odino i-block so access ed satan. ']
['Saray anunsio et nepeg ya ipawit ed sulat panamegley na e-mail (nengnengen so "Contact" section parad e-mail address). ']
['Unong ed DMCA, kaukolan ya ipila ed pakabat mo so onggendan ya impormasyon: (1) deskripsion na copyrighted ya kimey ya ibabagan inabuso; (2) deskripsion na ibabagan inabuso tan impormasyon ya magenap pian naromog mi itan; (3) impormasyon pian nakontak ka, kaiba lay address, numero na telepono, tan email address mo; (4) deklarasyon mo ya talagan papanisiaan mon say inusar mo et ag-inabuloyan na akankayaryan na copyright, odino na ahente to, odino na anggan anton ley; ']
['(5) sakey a deklarasyon ya pinirmaan mo, ya agmo aabuloyan ya palso so ibabaga na satan, ya susto so impormasyon ed samay inyanunsio tan walay autoridad mon mangipaakseb ed saray copyright ya ibabagan asakitan; ']
['tan (6) sakey a pisikal odino electronic signature na akankayarian na copyright odino sakey a toon naikdan na autoridad ya onkiwas parad akankayarian na copyright. ']
['No agmo ipila so amin ya impormasyon ed tagey, nayarin naabala so pangasikaso ed reklamo mo.']
['Kontak']
['Ipangasin ipawit ed sikami so antokaman a tepet / suhestion yo.']
How to treat lung cancer?
The treatment for lung cancer depends on several factors, including the stage of the cancer, the type of lung cancer, and the patient's overall health.
Some common treatment options include:
1. Surgery: This is often the preferred treatment for early-stage lung cancer.
The surgeon removes the tumor and a small portion of healthy tissue around it.
2. Radiation therapy: High-energy radiation is used to kill cancer cells and shrink tumors.
It can be used alone or in combination with other treatments.
3. Chemotherapy: This treatment uses drugs to kill cancer cells.
It can be given intravenously or or orally, and is often used in combination with other treatments.
4. Targeted therapy: This treatment targets specific genes or proteins that contribute to the growth and survival of cancer cells.
It is often used for advanced or metastatic lung cancer.
5. Immunotherapy: This treatment helps the immune system recognize and attack cancer cells.
It is often used for advanced or metastatic lung cancer.
6. Photodynamic therapy: This treatment uses a light-activated drug to kill cancer cells.
It is often used for early-stage lung cancer.
7. Proton therapy: This is a type of radiation therapy that uses protons instead of x-rays to deliver radiation to the tumor.
It is often used for early-stage lung cancer.
8. Clinical trials: Patients may be eligible to participate in clinical trials testing new treatments or combinations of treatments.
It is important to discuss the best treatment options with a healthcare team, as the most effective treatment plan will depend on the individual's specific situation.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Nipaakar ed']
['Uusaren na BioMedLib iray automated computer (machine-learning algorithms) pian makapanggaway parepareho iran tepet tan ebat.']
['Igapo tayo ed 35 milyon ya biomedical ya publikasyon na PubMed/Medline.']
